NLM Digital Collections

Search

Start Over Languages English ✖Remove constraint Languages: English Publication Year 2021 ✖Remove constraint Publication Year: <span class="single" data-blrl-single="2021">2021</span>

626. States’ backlogs of standard surveys of nursing homes grew substantially during the COVID-19 pandemic

Publication:
Washington, D.C. : U.S. Department of Health and Human Services, Office of Inspector General, July 2021
Subject(s):
Government Regulation
Health Care Surveys -- statistics & numerical data
Nursing Homes -- legislation & jurisprudence
COVID-19
United States
United States. Department of Health and Human Services

627. High-expenditure Medicare drugs often qualified for Orphan Drug Act incentives designed to encourage the development of treatments for rare diseases

Publication:
Washington, D.C. : U.S. Department of Health and Human Services, Office of Inspector General, September 2021
Subject(s):
Drug Development -- legislation & jurisprudence
Government Regulation
Medicare Part B -- economics
Medicare Part D -- economics
Orphan Drug Production -- economics
United States
United States. Department of Health and Human Services

628. CMS could improve the data it uses to monitor antipsychotic drugs in nursing homes

Publication:
Washington, D.C. : U.S. Department of Health and Human Services, Office of Inspector General, May 2021
Subject(s):
Antipsychotic Agents -- standards
Frail Elderly -- statistics & numerical data
Government Regulation
Nursing Homes -- legislation & jurisprudence
Vulnerable Populations -- legislation & jurisprudence
United States
United States. Department of Health and Human Services
Centers for Medicare & Medicaid Services (U.S.)

630. SAMHSA is missing opportunities to better monitor access to medication-assisted treatment through the buprenorphine waiver program

Publication:
Washington, D.C. : U.S. Department of Health and Human Services, Office of Inspector General, June 2021
Subject(s):
United States Substance Abuse and Mental Health Services Administration
Buprenorphine -- supply & distribution
Government Regulation
Opioid Epidemic
United States
United States. Department of Health and Human Services